402 related articles for article (PubMed ID: 27591142)
1. Suppression of hepatitis B virus antigen production and replication by wild-type HBV dependently replicating HBV shRNA vectors in vitro and in vivo.
Li B; Sun S; Li M; Cheng X; Li H; Kang F; Kang J; Dörnbrack K; Nassal M; Sun D
Antiviral Res; 2016 Oct; 134():117-129. PubMed ID: 27591142
[TBL] [Abstract][Full Text] [Related]
2. Exploring gene-deleted adenoviral vectors for delivery of short hairpin RNAs and reduction of hepatitis B virus infection in mice.
Rauschhuber C; Xu H; Salazar FH; Marion PL; Ehrhardt A
J Gene Med; 2008 Aug; 10(8):878-89. PubMed ID: 18470951
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of HBV replication in vivo using helper-dependent adenovirus vectors to deliver antiviral RNA interference expression cassettes.
Crowther C; Mowa MB; Ely A; Arbuthnot PB
Antivir Ther; 2014; 19(4):363-73. PubMed ID: 24296696
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of HBV replication and gene expression in vitro and in vivo with a single AAV vector delivering two shRNA molecules.
Li Z; He ML; Yao H; Dong QM; Chen YC; Chan CY; Zheng BJ; Yuen KY; Peng Y; Sun Q; Yang X; Lin MC; Sung JJ; Kung HF
BMB Rep; 2009 Jan; 42(1):59-64. PubMed ID: 19192395
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus inhibition in mice by lentiviral vector mediated short hairpin RNA.
Deng L; Li G; Xi L; Yin A; Gao Y; You W; Wang X; Sun B
BMC Gastroenterol; 2009 Oct; 9():73. PubMed ID: 19804649
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of multiple gene expression and virus replication of HBV by stable RNA interference in 2.2.15 cells.
Ren X; Luo G; Xie Z; Zhou L; Kong X; Xu A
J Hepatol; 2006 Apr; 44(4):663-70. PubMed ID: 16466826
[TBL] [Abstract][Full Text] [Related]
7. Long-term suppression of hepatitis B virus replication by short hairpin RNA expression using the scaffold/matrix attachment region-based replicating vector system pEPI-1.
Jenke AC; Wilhelm AD; Orth V; Lipps HJ; Protzer U; Wirth S
Antimicrob Agents Chemother; 2008 Jul; 52(7):2355-9. PubMed ID: 18474581
[TBL] [Abstract][Full Text] [Related]
8. The short hairpin RNA driven by polymerase II suppresses both wild-type and lamivudine-resistant hepatitis B virus strains.
Ren GL; Fang Y; Ma HH; Lei YF; Wang D; Xu MC; Wang PZ; Huang CX; Nie OH; Sun YT; Bai XF
Antivir Ther; 2007; 12(6):865-76. PubMed ID: 17926641
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus is inhibited by RNA interference in cell culture and in mice.
Ying RS; Zhu C; Fan XG; Li N; Tian XF; Liu HB; Zhang BX
Antiviral Res; 2007 Jan; 73(1):24-30. PubMed ID: 16844238
[TBL] [Abstract][Full Text] [Related]
10. RNA interference inhibits hepatitis B virus gene expression and replication in HepG2-N10 cells.
Ren JL; Pan JS; Cheng T; Dong J; Lu YP; Huang SJ; Shi HX; Wang L; Lian YM
Chin J Dig Dis; 2006; 7(4):230-6. PubMed ID: 17054586
[TBL] [Abstract][Full Text] [Related]
11. Use of RNA interference to modulate liver adenoma development in a murine model transgenic for hepatitis B virus.
Chen CC; Chang CM; Sun CP; Yu CP; Wu PY; Jeng KS; Hu CP; Chen PJ; Wu JC; Shih CH; Gershwin ME; Tao MH
Gene Ther; 2012 Jan; 19(1):25-33. PubMed ID: 21562593
[TBL] [Abstract][Full Text] [Related]
12. Effective inhibition of HBV replication in vivo by anti-HBx short hairpin RNAs.
Carmona S; Ely A; Crowther C; Moolla N; Salazar FH; Marion PL; Ferry N; Weinberg MS; Arbuthnot P
Mol Ther; 2006 Feb; 13(2):411-21. PubMed ID: 16337206
[TBL] [Abstract][Full Text] [Related]
13. Specific anti-viral effects of RNA interference on replication and expression of hepatitis B virus in mice.
Wu Y; Huang AL; Tang N; Zhang BQ; Lu NF
Chin Med J (Engl); 2005 Aug; 118(16):1351-6. PubMed ID: 16157029
[TBL] [Abstract][Full Text] [Related]
14. Quantitative assessment of the antiviral potencies of 21 shRNA vectors targeting conserved, including structured, hepatitis B virus sites.
Sun D; Rösler C; Kidd-Ljunggren K; Nassal M
J Hepatol; 2010 Jun; 52(6):817-26. PubMed ID: 20400195
[TBL] [Abstract][Full Text] [Related]
15. Combinatorial RNA Interference Therapy Prevents Selection of Pre-existing HBV Variants in Human Liver Chimeric Mice.
Shih YM; Sun CP; Chou HH; Wu TH; Chen CC; Wu PY; Enya Chen YC; Bissig KD; Tao MH
Sci Rep; 2015 Oct; 5():15259. PubMed ID: 26482836
[TBL] [Abstract][Full Text] [Related]
16. 5'-triphosphate-siRNA activates RIG-I-dependent type I interferon production and enhances inhibition of hepatitis B virus replication in HepG2.2.15 cells.
Chen X; Qian Y; Yan F; Tu J; Yang X; Xing Y; Chen Z
Eur J Pharmacol; 2013 Dec; 721(1-3):86-95. PubMed ID: 24099962
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic inhibition of hepatitis B virus surface antigen expression by RNA interference.
Cheng TL; Chang WW; Su IJ; Lai MD; Huang W; Lei HY; Chang WT
Biochem Biophys Res Commun; 2005 Oct; 336(3):820-30. PubMed ID: 16153600
[TBL] [Abstract][Full Text] [Related]
18. Stable inhibition of hepatitis B virus proteins by small interfering RNA expressed from viral vectors.
Moore MD; McGarvey MJ; Russell RA; Cullen BR; McClure MO
J Gene Med; 2005 Jul; 7(7):918-25. PubMed ID: 15756649
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of hepatitis B virus replication by APOBEC3G in vitro and in vivo.
Lei YC; Hao YH; Zhang ZM; Tian YJ; Wang BJ; Yang Y; Zhao XP; Lu MJ; Gong FL; Yang DL
World J Gastroenterol; 2006 Jul; 12(28):4492-7. PubMed ID: 16874860
[TBL] [Abstract][Full Text] [Related]
20. Activity of stabilized short interfering RNA in a mouse model of hepatitis B virus replication.
Morrissey DV; Blanchard K; Shaw L; Jensen K; Lockridge JA; Dickinson B; McSwiggen JA; Vargeese C; Bowman K; Shaffer CS; Polisky BA; Zinnen S
Hepatology; 2005 Jun; 41(6):1349-56. PubMed ID: 15880588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]